[ad_1]
The US Food and Drug Administration. USA He approved the use of the antiviral medication remdesivir for the treatment of Kovida 19, which means it can be used in hospitals across the United States.
CEO of the company “Gilied” that produces remdesivir Daniel O Day he said in a meeting with the president Donald trump that this is an “important first step” and that more than 1.5 million doses of the drug will be donated to hospitals, Reuters reports.
The donation should be enough to treat about 140,000 patients. The distribution of the drug is scheduled to begin on Monday.
Gilied has previously said that the intravenous drug remdesivir is helping to cure Kovid 19, and since there is no coronavirus vaccine, interest in the drug is high.
Data from the US National Institutes of Health. USA They showed that remdesvir reduced the length of hospitalization in approximately 31 percent of patients, but did not significantly affect the chances of survival.
The Institute for Clinical and Economic Research, which evaluates drug prices in terms of their effectiveness, said that production of remdesivir could cost $ 10, but could increase to 4,500 if clinical trials prove to be more effective.
Initially, Remdesivir was only available to patients participating in clinical trials, and approval from the Food and Drug Administration means that it can now be used in all hospitals.
However, given the limited amounts of the drug, it will first be delivered to hospitals in cities most affected by Kovid 19.
According to Reuters, more than 3.2 million people were infected worldwide with coronaviruses, while 232,800 died.
The United States has the highest victims in the world: 63,200.
